FDA nods for access to investigational drugs

FDA nods access to the investigational drugs that are not yet approved by FDA to seriously ill patients interested in gaining access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and don’t have other satisfactory treatment options.